Lucid Diagnostics dips after pricing $25M stock offering

2 hours ago 1

Lucid Diagnostics (NASDAQ:LUCD) fell over 17% premarket on Wednesday after it priced a public offering of 25 million shares at $1.00 each.
Underwriters also have a 30-day option to buy up to 3.75 million additional shares at the same price, excluding